Publications de la FMSP – Page 4

Liste des publications par enseignant de la Faculté de Médecine et des Sciences Pharmaceutiques (Page 4)

Page 1 | Page 2 | Page 3 | page 4 | Page 5 | Page 6 | Page 7 | Page 8

 

B- ENSEIGNANTS DES DIFFERENTS DEPARTEMENTS

Département de Chirurgie et Spécialités, Anesthésies et Réanimation

Auteur / Titre

8-Name: David Douglas Banga Nkomo

Academic Rank: Assistant Lecturer

Speciality: Cardiovascular and thoracic Surgery

Sub-speciality: Thoracic Surgery; Vascular Surgery

Address: P.O. Box 96 Dschang, Cameroon; Phone: +237657252578/667476367

E-mail : dbangankomo@yahoo.fr; dbangankomo@gmail.com

ORCID N°: 0000-0002-8663-229X; H index (Google Scholar):

PubMed:https://pubmed.ncbi.nlm.nih.gov/?term=Nkomo+DB&cauthor_id=33333085 https://pubmed.ncbi.nlm.nih.gov/?term=Banga+Nkomo+D&cauthor_id=32981609 https://pubmed.ncbi.nlm.nih.gov/?term=Nkomo+DDB&cauthor_id=32774594

PUBLICATIONS IN PEER-REVIEWED JOURNALS

2021

  1. Mbongo’o GC, Mbole J, Banga Nkomo DD, Menguene JL, Mendimi Nkodo JM, Awana AP5, Nko’o Amvene MR, Eyoum C, Basseguin Atchou JG, Ntone Enyime. Bilan d’un An d’Activités Médico-Hospitalières au Service B de Psychiatrie à l’Hôpital Jamot (Yaoundé). Health Sci. Dis: Vol 22 (2) February 2021 pp 73-79

2020

  1. Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Nkomo DB, Hassan M, Brindel A, Ruuth-Praz J, Schmitt P, Clément-Duchêne C, Douiri N, Reeb J, Prisciandaro E, Siat J, Spaggiari L, Ruffini E, Filosso P, Ferri L, Santelmo N, Spicer J, Renaud S. Safety and feasibility of thoracic malignancy surgery during the COVID-19 pandemic. Ann Thorac Surg. 2020 Dec 14; S0003-4975(20)32115-9. doi: 10.1016/j.athoracsur.2020.12.001.
  2. Joseph Seitlinger, Douglas Banga Nkomo, Arthur Streit, Florent Stasiak, Stéphane Renaud. Letter to the Editor Concerning the Article From Cai et al. Focusing on Coronavirus Disease 2019 Impact on Lung Cancer Resection, Published in June 2020. J Thorac Oncol. 2020 Oct;15(10):e172-e173. doi: 10.1016/j.jtho.2020.06.024.
  3. David Douglas Banga Nkomo et al. La crosse aortique droite avec aorte descendante gauche : une cause rare de dysphagie. Pan African Medical Journal. 2020; 36:17. [doi: 10.11604/pamj.2020.36.17.17206]

2019

  1. Doumbia M, Diarra B I, Diatta S, Diarra S, Banga DD Nkomo, Sawadogo A, Mariko M, Ciss AG, Ndiaye A and Ndiaye M. The Solitary Thoracic Schwannoma of the Intercostal Nerve: A Case Operated. J Clin Rev Case Rep, 2019 ; 4 (2):1-2
  2. Doumbia M, Kone S, Diatta S, Dara C, Diarra BI, Sawadogo A, Banga Nkomo DD, Maïga AA, Sidibe S, Mariko M, Ndiaye A and Ndiaye M. Unruptured Scissural
  3. Pleural Primitive Hydatid Cyst an Unusual Presentation of Intrathoracic Hydatic Cyst: A Case Report. Clin Case Rep Open Access. 2019; 2(2):125

2018

  1. Ndiaye A, Banga Nkomo DD, Diatta S, Ba PS, Gaye M, Dieng PA, Dia Y, Ciss AG, Ndiaye M. Indications et suites opératoires des pneumonectomies au Centre hospitalier universitaire national (CHUN) de Fann à Dakar. Journal de chirurgie thoracique et cardio-vasculaire 2018;22(4). doi: 10.24399/JCTCV22-4-NDI
  2. Ndiaye A, Banga Nkomo DD, Diatta S, Ba PS, Gaye M, Doumbia M, Dieng PA, Ciss AG, Ndiaye M. Indications et résultats de la chirurgie de résection des bulles d’emphysème pulmonaire.The Pan African Medical Journal. 2018; 31:48. doi:10.11604/pamj.2018.31.48.16160.

2017

  1. Assane Ndiaye, Souleymane Diatta, David Douglas Banga Nkomo, Papa Salmane Ba, Modibo Doumbia, Adama Sawadogo, Magaye Gaye, Fokalbo Zephanie Kobe, Momar Sokhna Diop, Ndeye Fatou Sow, Gabriel AmadouCiss, Pape Adama Dieng, Mohamadou Lamine Fall, Mouhamadou Ndiaye. Thoracoplasty in the Management of Chronic Empyema: Experience of a Sub Saharan African Country. International Journal of Cardiovascular and Thoracic Surgery. 3, No. 6, 2017, pp. 70-74. doi: 10.11648/j.ijcts.20170306.12

2016

  1. Souleymane Diatta, Modibo Doumbia, Momar Sokhna Diop, David Douglas Banga Nkomo et al. Pneumatocele occurred by anterior mediastinotomy, an unusual complication of Chamberlain procedure. Sch J Med Case Rep 2016; 4(10):782-784.

9- Nom et Prénoms: DONGMO Arlette Michelle

Rang académique: Assistante

Spécialité: Chirurgie Générale

Sous-spécialité: Chirurgie Digestive

Téléphone: 6.99.66.26.23

Mel: arlettedongmo@yahoo.fr

————————————————————————————————

  PUBLICATIONS

2021

1–Dongmo A.M, Banga Nkomo D, Mekeme J.B, Eya S, Kamga J, Bitang A Mafok L.J. Prise en charge d’une plaie rénale à présentation atypique, en contexte de polytraumatisme, au centre des urgences de yaoundé; à propos d’un cas. Dans: Société Camerounaise de Chirurgie Digestive, directeur. Journal des abstracts. ‘Pratique de la chirurgie digestive au Cameroun: formation, enjeux, défis et perspective’, mai 2021, Yaoundé, Cameroun. Yaoundé : Cameroun, 2021, p. 50.

2020

  • Essola B, Mbarga Mvogo C, Engbang Ndamba J.P, Bitang L.J, Dongmo A, Ngowe Ngowe M, Essomba A.“Les plaies pénétrantes de l’abdomen avec éviscération: aspects cliniques,thérapeutiques et pronostiques sur 2 centres à Yaoundé”. Revue de médecine et de pharmacie 2020; Vol 10, N° 2

2010

3-Takongmo S, Monabang C, Masso Misse P, Dongmo A, Sando Z, Nko´o A. S. “Apport de l’imagerie médicale dans le diagnostic des cancers familiaux du sein à Yaoundé. A propos de cinq cas cliniques”. Afr J Med Imag 2010; (3), 3: 167-173

4-Takongmo S, Sando Z, Monabang C, Dongmo A, Essame Oyono JL, Nko’o S. “Prise en charge des cancers de la vésicule biliaire.A propos de deux cas traités au CHU de Yaoundé (CAMEROUN)”. J Afr Chir Digest 2010; VOL 10 (1) : 1028 – 1031

5-Takongmo S; Nkwabong E; Sando Z; Dongmo A; Monabang C; Nko’o S. “A Case report of a Giant fallopian tube leiomyoma mimicking a mesenteric tumor”. Clin Mother Child Health 2010; Vol 7, N° 1: 1229 – 1231

2009

6-Takongmo S, Dongmo A, Monabang C, Masso Misse P, Nko’o S. “ Tomodensitométrie et traitement chirurgical des tumeurs abdominales. À propos de 45 cas”. J Afr Imag Méd 2009; (3), 1: 11-15

7-Takongmo S, Gonsu Kamga H, Dongmo A, Masso Misse P, Monabang C, Nko’o S. “Abcès abdominal pseudo-tumoral chez un sujet séropositif au virus de l’immunodéficience humaine sous tri-thérapie”. Health Sci. Dis: Vol 10 (1) (March 2009) : 27-30

 

10-Name: Faustin ATEMKENG TSATEDEM

Academic Rank: Lecturer

Speciality: Sugery,

Sub-speciality: Orthopaedics, Traumatology

Address: P.O. Box 96 Dschang, Cameroon; Phone: +237 677779204

E-mail: faustin.atemkeng@univ-dschang.org; atemfaust@yahoo.fr

ORCID N°: 0000-0002-3530-2637; H index (Google Scholar):

PubMed:

PUBLICATIONS

 2021

  1. Atemkeng Tsatedem Faustin, Nanfack Noutsawo Hans William, Fondop Joseph, Tsafack Etienne and Akaba Désiré. Preliminary study of obstetric paralysis of the brachial plexus at the national centre for disabled persons in yaoundé, cameroon, about a cohort of 15 cases: frequency, physiotherapy techniques and short-term results of conservative treatment in a resource-limited country. J. Adv. Res. 9(07), 1055-1060 doi: 10.21474/IJAR01/13212.
  2. Boris Amougou, Yaya Sow, Arlette Dongmo, David Douglas Banga Nkomo, Jean Paul Engbang, Theodore Sala Beyeme, Joseph Fondop, Demba Cisse, Faustin Atemkeng, Boubacar Fall, Babacar Diao, Abdoulaye Bobo Diallo, Alain Khassim Ndoye, Fru Angwafor III, Mamadou Ba. Cytoreductive Nephrectomy in Metastatic Kidney Cancer: Experience of the Urology Department at Aristide Le Dantec University Teaching Hospital. International Journal of Clinical Urology. 2021; 5(2): 74-79 doi: 10.11648/j.ijcu.20210502.14.

2018

  1. Marc Leroy Guifo, Marie Ange Ngo Yamben, Farikou Ibrahima, Franck Olivier Ngongang, Tsatedem Faustin Atemkeng, Gaspary Fodjeu, Arthur Georges Essomba. Traitement chirurgical des fractures du bassin au CHU de Yaoundé : analyse rétrospective de 13 cas. Revue de Chirurgie Orthopédique et Traumatologique Doi : 10.1016/j.rcot.2018.05.011 received : 28 February 2018; accepted :18 May 2018.
  2. Atemkeng Tsatedem Faustin, Wondjè Fouda Thérèse Fernande, Nguéné Nyemb André Georges, Necdem stéphanie, and Nguifo Marc Leroy. Clubfoot treatment by the Ponseti method in Yaounde, about a cohort of 74 cases. J. Adv. Res. 6(11), Novembre 2018 p953-959.
  3. Chu Buh Franklin, Vukugah Achombwom Thomas, Ghyslaine Bruna Djeunang Dongho, Atemkeng Tsatedem Faustin, Krishna Nand Sharma. Conventional Physiotherapy and Additional Krishna’s Kinetikinetic Manual Therapy (KKMT) For Knee Osteoarthritis Rehabilitation: A Comparative Study. International Journal of Advanced Research Volume 2 Issue 1, January 2018 pp 54-58.

2016

  1. Elizabeth J. F. Metemo, Samuel Nambile Cumber, Jackson Jr N. Ndenkeh, Joyce Mahlako Tsoka-Gwegweni and Atemkeng Faustin. Functional impact of proprioceptive neuromuscular facilitation in the management of post stroke hemiplagia in Bafoussam Regional Hospital, Cameroon. International Journal of Advanced Research 2016 5(5), pp 49-56 DOI: 10.21474/IJAR01/4077.
  2. Mohamadou AS, Faustin AT, Gustave TJ, Richard NP, Alphonse B. Inappropriate Physiotherapy: An Unusual Factor of Implant Failure in Douala. J Trauma Treat (2016) 5: 323. DOI:10.4172/2167-1222.1000323

2015

  1. Schwartz, F. Atemkeng, T. Messaoudi. Review of 41 Neer’s mini-open operations with up to nine-year follow-up and a study of the influence of occupational disease. Eur J Orthop Surg Traumatol (2015) 25:717–721 DOI 10.1007/s00590-014-1580-3
  2. Mohamadou AS, Faustin AT, Gustave TJ, Richard NP, Alphonse B. A Four-Year Study of Complex Fractures around the Knee in Laquintinie Hospital of Douala. Journal of Trauma and Treatment (2015) 4: 268. DOI:10.4172/2167-1222.1000268

2014

  1. Guifo ML, Atemkeng Tsatedem F, Bitang Mafok LJ, Pisoh Tangnyin C, Ndoumbé A, Takongmo S. Traitement systématique des fractures du fémur et du tibia par enclouage non alésé dans un pays en développement. A propos d’une série en cours au centre hospitalier et universitaire de Yaoundé. Revue de Chirurgie d’Afrique Centrale (RECAC) Volume 2, Numéro 4. Juin 2014 pp 65- 69.

2012

  1. Faustin Atemkeng Tsatedem, Jean Gustave Tsiagadigui, Richard Polle Ndando, Mohamadou Saidou Arabo, Alphonse Bayiha, Bruno Kenfack. Décision d’amputation dans la prise en charge initiale d’une luxation ouverte grave de la cheville à propos d’un cas observé à l’Hôpital Laquintinie de Douala suite à un accident par moto-taxi. The Pan African Medical Journal. 2012; 13:73
  2. Bruno Kenfack, Michel Noubom, Adamo Bongoe, Tsatedem Faustin Atemkeng, Modeste Ngono, Georges Nguefack Tsague, Emile Mboudou. La grossesse extra-utérine dans une région semi-rurale en Afrique: Aspects épidémiologiques, cliniques et thérapeutiques à propos d’une série de 74 cas traités à l’Hôpital de District de Sangmelima au Sud-Cameroun. The Pan African Medical Journal. 2012;13:71
  3. Arabo, T.F Atemkeng, R. Ndando, A. Bayiha, G. Tsiagadigui. La neuropraxie grave du sciatique secondaire à une fracture-luxation postéro-supérieure de la hanche : à propos d’un cas à Douala. The bilingual journal of Orthopaedics and Emergency Surgery Vol. 01 N° 02 July-September 2012.
  4. H. Moby Mpah, F. Atemkeng Tsatedem, T Sala Beyeme, P. J. Fouda and F. Angwafo. Un accident de travail peu ordinaire : embrochage de la verge par une esquille de bois. Andrology. March 2012, volume 22, Issue 1, pp 49-50

2010

  1. Arabo, G Tsiagadigui, R Ndando, F Atemkeng, A Bayiha. Luxation tarso-métatarsienne : à propos d’un cas survenu chez un conducteur de deux roues Revue Africaine de Chirurgie et Spécialités –Vol 4, No 9 (2010) pp 41-42 SM
  2. Guifo Marc Leroy, Takongmo Samuel, Chichom Alain, Pisoh Tagnyin Christopher, Atemkeng Tsatedem Faustin, Fokou Markus. Abcès appendiculaires : analyse de 19 cas traités au Centre hospitalier et Universitaire de Yaoundé et déductions pratiques. The Pan African Medical Journal. 2010; 5:25

 BOOK CHAPTERS

  1. Krishna Nand Sharma, Chu Buh Franklin and Atemkeng Tsatedem Faustin Krishna’s Kinetikinetic Manual Therapy (KKMT) and alternative therapy For Knee Osteoarthritis Rehabilitation, Lambert publishing India 2019

11-Name: Boris AMOUGOU

Academic Rank: Assistant

Speciality: Urology

Sub-speciality:

Address: P.O. Box 96 Dschang, Cameroon; Phone: +237 695 260 971

E-mail: risboamougou@yahoo.fr

ORCID N°: 0000-0003-3426-3370; H index (Google Scholar):

PubMed:

 2021

  • Demba Cisse, Alpha Oumar Barry, Mamadou Diao Bah, Houssein Fofana, Mamadou Barry, Thierno Mamadou Oury Diallo, Mamadou Bissiriou Bah, Daouda Kante, Boris Amougou, Flora Fondjo Tchatche, Abdoulaye Bobo Diallo, Oumar Raphiou Bah. The Wooden Rod Foreign Body in the Urethra after Self-Dilatation of the Urethra Stricture: Case Report in the National Hospital of Ignace Deen Conakry (Guinea). Open Journal of Urology 2021;11(9):313-316.
  • Boris Amougou, Yaya Sow, Arlette Dongmo, David Dougla Banga Nkomo, Jean Paul Engbang, Theodore Sala Beyeme, Joseph Fondop, Demba Cissé, Faustin Atemkeng, Boubacar Fall, Babacar Diao, Abdoulaye Bobo Diallo, Alain Khassim Ndoye, Fru Angwafor III, Mamadou Ba. Cytoreductive Nephrectomy in Metastatic Kidney Cancer: Experience of the Urology Department at Aristide Le Dantec University Teaching Hospital. International Journal of Clinical Urology 2021;5(2):74-79.
  • Boris Amougou, Divine Eyongeta, Demba Cissé, Marcel Jerry Ngandeu, Jean Paul Engbang, Rodrigue Djoufang, Theodore Sala Beyeme, Yaya Sow, Abdoulaye Bobo Diallo, Fru Angwafor III. Les hernies inguinales de l’adulte à l’Hôpital Central de Niété : Aspects épidémiologiques et anatomocliniques. Health Sci Dis. 2021;22(7):107-111.
  • Boris Amougou, Divine Eyongeta, Jean Paul Engbang, Theodore Sala Beyeme, Demba Cissé, Marcel Jerry Ngandeu, Yaya Sow, Abdoulaye Bobo Diallo. Rhabdomyosarcome paratesticulaire : à propos d’un cas et revue de la littérature. Pan African Medical Journal. 2021;39:71.

2010

  • Bobo Diallo, I. Bah, T.M.O. Diallo, O.R. Bah, B. Amougou, M.D. Bah, S. Guirassy, M. Bobo Diallo. Le profil des urgences urologiques au CHU de Conakry, Guinée. Prog. Urol. 2010; 20:214-21

2009

  • Bah, A. Bobo Diallo, T. Camara, M.L. Bah, T.M.O. Diallo, B. Amougou, K. Kouyaté, M. Bobo Diallo. Les complications urinaires des traumatismes du bassin : aspects anatomocliniques et thérapeutiques au CHU de Conakry, Guinée. Androl. 2009;19:203-208.

 

 Département de Santé Publique

12- Name : Jerome ATEUDJIEU

Academic Rank: Associate Professor

Speciality: Public Health,

Sub-speciality: Epidemiology

Address: P.O. Box 96 Dschang, Cameroon; Phone: +237 699701011

E-mail: jerome.ateudjieu@univ-dschang.org; jateudj@yahoo.fr

ORCI N°; Google Scholar: https://scholar.google.com/citations?user=-AxW3eMAAAAJ&hl=fr

PubMed: ateudjieu – Search Results – PubMed (nih.gov)

  PUBLICATIONS IN PEER-REVIEWED JOURNALS

2021

  1. Ateudjieu J,Yakum NM , Goura AP , Guenou E , Bita’a Beyala L, Amada L, Ngoche I, Kiadjieu FF, Nangue C, Soukep Djosseu EB, Kenfack B. Tracking Demographic Movements and Immunization Status to Improve Children’s Access to Immunization (TDM-IAI): Protocol for a Field-Based Randomized Controlled Trial. JMIR Res Protoc 2021 Feb 8;10(2):e21734. doi: 10.2196/21734,
  2. Esong MB, Goura AP, Mbatchou BHN, Walage B, Simo HSY, Medjou RM, Sonkoue MP, Djouda CD, Ngnewa RSF, Guiagain MST, Agokeng BK, Homla OTM, Pope D, Ateudjieu J. Distribution of sources of household air pollution: a cross-sectional study in Cameroon. BMC Public Health. 2021 Feb 8;21(1):318. doi: 10.1186/s12889-021-10350-6,
  3. Douanla IMK, Ntsekendio PN, Dieumo FFK, et al. Training Needs Of Research Ethics Committee Members In Cameroon Regarding Research Participant Protection. Research Square; 2021. DOI: 10.21203/rs.3.rs-397098/v1,
  4. Nguemouo Nguegang I, Nguetsop M, Eba Ze LE, Anyambod Mboh I, Omokolo DM, Noutakdie Fossi R, Guenou E, Ateudjieu J. Tracking Demographic Movements and Immunization Status to Improve Children’s Access to Immunization (TDM-IAI): Protocol for a Field-Based Randomized Controlled Trial. JMIR Research Protocols 10 (2), e21734
  5. Wandji Takemegni MJ, Ateudjieu J, Enow Orock G, Mbopi-Keou FX, Ngowe Ngowe M. Pattern of antibiotics resistance and phenotypic characterization of Multidrug resistant bacteria isolates in four hospitals of Littoral region, Cameroon. Journal of Drug Delivery and Therapeutics 11 (1-s), 20-30

2020

  1. Ateudjieu, J., Yakum, M., Goura, A.P. et al.EPI immunization coverage, timeliness and dropout rate among children in a West Cameroon health district: a cross sectional study. BMC Public Health 20, 228 (2020). https://doi.org/10.1186/s12889-020-8340-6
  2. Takemegni Wandji JM, Assob Nguedia JC, Ateudjieu J, Enow Orock G, Ngowe Ngowe M. Major Bacteria Species Surface Contaminants in Hospitals of Littoral Region, Cameroon. European Journal of Clinical and Biomedical Sciences 6 (3), 26-34
  3. Ateudjieu J, Stoll B, Bisseck AC, Tembei MT, Genton G. Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies. Human vaccines & immunotherapeutics 16 (6), 1245-1259
  4. Dongmo NT, Mutombo B, Ateudjieu J, Tengomo GF, Kwengani M, Gabo P, Diwampovesa MCG, Akilimali L, Miwanda B, Nkwesheu A, Bangonda M, Noubom M, Mbopi-Keou FX. Cholera Outbreak in the Kasaï Oriental Province, Democratic Republic of Congo (DRC), 2018: The Case Fatality Rate in Mbuji-Mayi City and in the Rural Area. Science Journal of Public Health 2020; 8(1): 8-18
  5. Sonkoue MP, Momo Kadia B, Baame Esong M, Djouda Douanla C, Ateudjieu J. Smartphone addiction and its association with common mental disorders among students attending the university of Dschang, West region, Cameroon. Preprint Sever for health sciences. doi:https://doi.org/10.1101/2020.02.29.20029405

2019

  1. Agokeng Kemnang BD, Bita’a LB, Yomi SHS, Djidjou BT, Mboumo RM, Douanla CD, Wouafack-Kenfack V, Tsakeng FN, Homla Megaptche OT, Ateudjieu J. Distribution et itinéraire thérapeutique des patients reçus pour accident vasculaire cérébral à l’Hôpital Régional de Bafoussam, Cameroun [Distribution and therapeutic path of patients with stroke admitted to Hospital]. Pan Afr Med J. 2019 Dec 4;34: 174. French. doi: 10.11604/pamj.2019.34.174.19928.
  2. Ateudjieu J, Hurst S, Yakum MN, Tangwa GB. Biomedical research ethics in Cameroon: a survey to assess training needs of medical residents and students. BMC Med Educ. 2019 Jan 3;19(1):5. doi: 10.1186/s12909-018-1431-8. PMID : 30606193; PMCID: PMC631883
  3. Bayiha EJ, Kangmo C, Tachegno GVB, Bissek AZK. Health facility preparedness for cholera outbreak response in four cholera-prone districts in Cameroon: a cross sectional study. BMC Health Serv Res. 2019 Jul 8;19 (1):458. doi: 10.1186/s12913-019-4315-7. PMID: 31286934; PMCID: PMC6615310.
  4. Chukuwchindun BA, Goura AP, Bita’a Beyala L, Njimbia Chebe A, Gael Bita AI, Azakoh Nguefack J, Ateudjieu J. Pratiques alimentaires des mères et malnutrition infantile dans le district de santé de Pitoa: Etude cas-témoin. BirEx Journal 1 (4), 144-155
  5. Bénard AHM, Guenou E, Fookes M, Ateudjieu J, Kasambara W, Siever M, Rebaudet S, Boncy J, Adrien P, Piarroux R, Sack DA, Thomson N, Debes AK. Whole genome sequence of Vibrio cholerae directly from dried spotted filter paper. PLoS Negl Trop Dis. 2019 May 30;13(5):e0007330. doi: 10.1371/journal.pntd.0007330.
  6. Ayok MT, Yakum NM, Ebode M, Chebe A, Nafack S, Goura A, Cheugeu M, Guemechio N, Azakoh J, Bissek AC, Ateudjieu J. assessment of the data quality and standard of out patient registration for detection of cholera cases in CAMEROON. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2019 : 101, 152-152
  7. Ela ME, Cumber SN, Dakenyo RD, Tekam DD, Heumou PCB, Marvin GL, Ateudjieu J, Tsakoue EF. Association entre le paludisme et le faible poids de naissance à Yaoundé, Cameroun [Association between malaria and low birth weight in Yaounde, Cameroon]. Pan Afr Med J. 2019 Jun 21; 33:127. French. doi: 10.11604/pamj.2019.33.127.18101. PMID: 31558926; PMCID: PMC6754849.
  8. Goura AP, Chukuwchindun BA, Yakum MN, Azakoh Nguefack J, Lonbe PE, Ateudjieu J. Geographical Distribution of HIV-patients with Respect to HIV-treatment Units in Cameroon: A Cross-sectional Study. nternational Journal of HIV/AIDS Prevention, Education and Behavioural Science 2019; 5(1): 59-67
  9. Dongmo N.T, Mutombo M.B, Ateudjieu J, Folefack T.G, Gabo P, Miwanda N.B, Akilimali L, Tshizemba M.A, Diwampovesa M.C.G. a case-control study to identify risk factors related to cholera outbreak in kasai oriental province, DEMOCRATIC REPUBLIC OF CONGO, 2018. DOI: 10.21522/TIJPH.2013.08.01. Art 029.

2018

  1. Ateudjieu J, Bita’a LB, Guenou E, et al. [Profile and antibiotic susceptibility pattern of bacterial pathogens associated with diarrheas in patients presenting at the Kousseri Regional Hospital Anne, Far North, Cameroon. The Pan African Medical Journal. 2018;29: 170. DOI: 10.11604/pamj.2018.29.170.14296. PMID: 30050634; PMCID: PMC6057583.
  2. Mbunka MA, Ateudjieu J, Bayiha EJ, Yakum NM, Cheugueu DM, Dooh HC, Foyou DA, Watcho P, Zoung-Kanyi Bac. Raining Needs Assessment of Health Personnel on The Management of Diabetes Mellitus In The West Region Of Cameroon. Ijarp. 2018 March;2(3):59-64

2017

2017

  1. 22. Ebile AW, Ateudjieu J, Djuidje NM, Yakum NM, Watcho P. Map of biomedical research in Cameroon; a documentary review of approved protocols from 1997 to 2012. Global Healt 2017 Nov 21; 13 (1):85. doi: 10.1186/s12992-017-0312-y

23.Yakum MN, Ateudjieu J, Guenou E, et al. Health seeking behaviour among suspected cases of cholera in Cameroonian health districts in Lake Chad basin. BMC Res Notes. 2017; 10 (1):433. Published 2017 Aug 30. doi: 10.1186/s13104-017-2756-9

  1. 24. Beyala L, Etienne G, Anthony N, Benjamin A, Ateudjieu J. resistance of enteropathogens mainly associated with diarrhoea to frequently prescribed antibiotics in kousseri (far north, cameroon. BMJ Global Health2017; 2:

2016

25.Nouetchognou JS, Ateudjieu J, Jemea B, Mesumbe EN, Mbanya D. Surveillance of nosocomial infections in the Yaounde University Teaching Hospital, Cameroon. BMC Res Notes. 2016 Dec 8;9(1):505. DOI: 10.1186/s13104-016-2310-1

26.Djouma FN, Ateudjieu J, Ram M, Debes AK, Sack DA. Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based Survey. Am J Trop Med Hyg. 2016 Dec 7;95 (6):1287-1291. Epub 2016 Oct 17. DOI: 10.4269/ajtmh.16-0300

27.Ateudjieu J, Stoll B, Nguefack-Tsague G, Yakum MN, Mengouo MN, Genton B. Incidence and types of adverse events during mass vaccination campaign with the meningococcal a conjugate vaccine (MENAFRIVAC™) in Cameroon. Pharmacoepidemiol Drug Saf. 2016 Oct;25 (10):1170-1178. doi: 10.1002/pds.4027

28.Ebile Akoh W, Ateudjieu J, Nouetchognou JS, Yakum MN, Djouma Nembot F, Nafack Sonkeng S, Saah Fopa M, Watcho P. The expanded program on immunization service delivery in the Dschang health district, west region of Cameroon: a cross sectional survey. BMC Public Health. 2016 Aug 17;16 (1):801. doi: 10.1186/s12889-016-3429-7

29.Nkamedjie PPM, Ekukole ESR, Mabvouna BR, Bita IAG, Ateudjieu J. Access to potable water in Dschang Health District, A cross sectional study.IJR. 2016 June;3(10):1346-61

30.Nouetchognou JS, Ateudjieu J, Jemea B, Mbanya D. Accidental exposures to blood and body fluids among health care workers in a Referral Hospital of Cameroon. BMC Res Notes. 2016 Feb 15;9: 94. doi: 10.1186/s13104-016-1923-8

  1. 31. Debes AK, Ateudjieu J, Guenou E, Ebile W, Sonkoua IT, Njimbia AC, Steinwald P, Ram M, Sack DA. Clinical and Environmental Surveillance for Vibrio cholerae in Resource Constrained Areas: Application During a 1-Year Surveillance in the Far North Region of Cameroon. Am J Trop Med Hyg. 2016 Mar;94(3):537-543. doi: 10.4269/ajtmh.15-0496

2015

  1. 32. Fokunang C, Tembe-Fokunang E, Sando Z, Ngounoue-Djuidje M, Tiedeu BA, Kechia F, Ateudjieu J, Ndikum V, Langsi R, Fomnboh D, Fokam J, Gwum L, Abena O, Asongani T, Titanji VD, Kaptue L. The Public Health perspective on Migratory Health – Displaced Populations in Global Disease Epidemic. Intech Open: 2015 DOI: 10.5772/59069
  2. Tsafack M, Ateudjieu J. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone « beep » in a Cameroon health district: a randomized
  3. 34. Ebile AW, Ateudjieu J, Yakum MN, Djuidje MN, Watcho P. Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols. BMC Med Ethics. 2015 Sep 29;16 (1):67. doi: 10.1186/s12910-015-0061-5
  4. 35. Kenfack B, Nguefack-Tsague G, Ateudjeu J, Che GA, Mboudou ET. Fertility after ectopic pregnancy in a district hospital in Cameroon. Int J Gynaecol Obstet. 2015 Aug; 130(2):165-8. doi: 10.1016/j.ijgo.2015.02.027. Epub 2015 Apr 18

36.Yakum MN, Ateudjieu J, Pélagie FR, Walter EA, Watcho P. Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon. BMC Res Notes. 2015 Jun 30;8: 277. doi: 10.1186/s13104-015-1257-y

37.Tembe-Fokunang E, Fokunang C, Sando Z, Atogho-Tiedeu B, Kechia F, Ndikum V, Ngounoue-Djuidje M, Ateudjieu J, Langsi R, Fomnboh-Dobgima J, Fokam J, Gwum L, Abena OMT, Tazoacha-Asonganyii, Ngongang J, Titanji VK, Kaptue L. An Overview of The Public Health Global Perspective on the Grand Challenges of Non-Communicable and Chronic Diseases Within the Framework for Developing new Drugs. In: Asnake GE, dir: IntechOpen: 2015 DOI: 10.5772/59070

38.Yakum MN, Ateudjieu J, Walter EA, Watcho P Vaccine storage and cold chain monitoring in the North West region of Cameroon: a cross sectional study. BMC Res Notes. 2015 Apr 14;8: 145. doi: 10.1186/s13104-015-1109-9

  1. 39. Djouma FN, Noubom M, Ateudjieu J, Donfack H. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon. BMC Infect Dis. 2015 Mar 21;15: 139. doi: 10.1186/s12879-015-0876-1

2014

  1. Ateudjieu J, Stoll B, Nguefack-Tsague G, Tchangou C, Genton B. Vaccine safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial. Vaccine. 2014 Sep 29;32 (43):5662-8. doi: 10.1016/j.vaccine.2014.08.012.

 

 

2013

  1. Ateudjieu J, Kenfack B, Wakam-nkontchou B and Demanou M. Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon. BMC Research Notes 2013, 6:101 doi: 10. 1186/1756-0500-6-101.

2012

  1. Kenfack B, Ateudjieu J, Fouelifack YF, Tebeu P. M, Dohbit J and Mbu RE. Does the Advice to Assume the Knee-Chest Position at the 36th to 37th Weeks of Gestation Reduce the Incidence of Breech Presentation at Delivery? Clinics in Mother and Child Health 2012; (9): 5P doi:10.4303/cmch/C120601. URL: https://www.ajol.info/index.php/cmch/article/view/82028

2010

  1. Ateudjieu J, Williams J, Hirtle M, Baume C, Ikingura J, Alassane N, Sprumont D. Training needs assessment in research ethics evaluation among research ethics committees’ members in three African countries: Cameroon, Mali and Tanzania. Dev World Bioeth. 2010 Aug;10 (2):88-98 doi: 10.1111/j.1471-8847.2009.00266. URL: https://www.ncbi.nlm.nih.gov/pubmed/19912281
  2. 44. Mbanya D, Ateudjieu J, Tagny CT, Moudourou S, Monny l, Katue L. Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon. Int J Environ Res Public Health. 2010 May;7 (5):2085-100. doi: 10.3390/ijerph7052085

 

BOOK AND BOOK CHAPTER
  1. Ateudjieu J. Pharmacovigilance during mass immunization campaign with MenAfrivacτm in Cameroon. 2015, Doctoral Thesis of epidemiologye, University of Basel, Faculty of Science. doi: 10.5451/unibas-006514263
  2. Ateudjieu J, « Besoins en formation en éthique de la recherche auprès des étudiants résidents en médecine et des membres des comités d’éthique au Cameroun », in Ch. Hervé, M. Stanton Jean, M A Grimaud et C. Ribau (dir.), Pour des recherches biomédicales communes avec les pays du sud, Dalloz, coll. « Thèmes et commentaires », 2010

13- Name: Charles KOUANFACK

Academic Rank: Senior lecturer

Speciality: Public Health

Option: Epidemiologist

Adress : Ngousso résidentiel, P.O. Box 5555 Yaoundé

Tel : +237 699 950 743

E-mail : charleskouanfack@yahoo.fr

Pubmed:https://www.ncbi.nlm.nih.gov/myncbi/charles.kouanfack.1/bibliography/public/

ORCID N° : 0000-0002-0238-6205

PUBLICATIONS IN PEER-REVIEWED JOURNALS

2021

  1. Eugene Sobngwi, Sylvain Zemsi, Magellan Guewo-Fokeng, Jean-Claude Katte, Charles Kouanfack, Liliane Mfeukeu-Kuate, Armel Zemsi, Yves Wasnyo, Antoinette Assiga Ntsama, Arnaud Ndi-Manga, Joelle Sobngwi-Tambekou, William Ngatchou, Charlotte Moussi Omgba, Jean Claude Mbanya, Pierre Ongolo Zogo, Pierre Joseph Fouda. Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV). medRxiv07.25.21260838; doi: https://doi.org/10.1101/2021.07.25.21260838
  2. Vicky Jocelyne Ama Moor1,2*, Constant Anatole Pieme1, Jan René Nkeck1, Prosper Cabral Biapa Nya3, Georges Ikomey Mondinde1, Falmata Amazia1, Charles Kouanfack4, Marie Claire Okomo Assoumou1 and Jeanne Ngogang1. “Effects of Spirulina platensis on the Immune Status, Inflammatory and Oxidative Markers of HIV Patients on Antiretroviral Therapy in Cameroon ». Acta Scientific Pharmaceutical Sciences3 (2021): 50-57.
  3. Kowo MP, Frungwa CN, Njonnou SRS, Andoulo FA, Ndam AWN, Yemeli LD, Djeunga HCN, Kouanfack C, Kamgno J. Epidemiologic Patterns of HIV, Hepatitis B and C Virus Infections Among Refugees of the Mbile Camp in the East Region of Cameroon (Hepatitis and HIV among refugees). Journal of Gastroenterology and Hepatology Research 2021; 10(3): 2524-2530 Available from: URL: http://www.ghrnet.org/index.php/joghr/article/view/3056
  4. Charles Kouanfack1,2,3, Liliane Mfeukeu2,4, Sylvain Zemsi2, Martine Etoa2,4, Armel Zemsi2, Yvan Mbakop1,2, Martial Lantche3, Eric Youm5, Jean Claude Mbanya2,4, Pierre Joseph Fouda2,4, Pierre Ongolo Zogo2,4,6, Eugène Sobngwi2,3. Clinical, biochemical and CT-scan characteristics of obesity onset in patients under Dolutegravir in comparison with Low-dose-Efavirenz: a pilot study in Cameroon Health Sci. Dis: Vol 22 (3) March 2021 pp 1-8
  5. Molloy SF, Ross B, Kanyama C, Mfinanga S, Lesikari S, Heyderman RS, Kalata N, Ellis J, Kouanfack C, Chanda D, Temfack E, Lakhi S, Moodley A, Chan AK, van Oosterhout JJ, Mapoure Y, Mwaba P, Lalloo DG, Wang D, Lortholary O, Jaffar S, Hosseinipour MC, Loyse A, Harrison TS, Bicanic T. Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis. Open Forum Infect Dis. 2021 Feb 5;8 (4) of ab066. doi: 10.1093/ofid/ofab066. E Collection 2021 Apr. PMID: 33937434 Free PMC article.
  6. Kouanfack C, Lekelem SN, Bede F, Nkfusai CN, Nouafo YM, Tchokonte C, Zephirin NT, Fouda PJ. Use of Trained Non-Medical Staff to Improve Access to HIV Testing Services in Africa: Implementation of the World Health Organization Opt-out Approach in Cameroon. Int J MCH AIDS. 2021; 10 (1):119-127. doi: 10.21106/ijma.426. Epub 2021 Apr 8. PMID: 33868777 Free PMC article.
  7. Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. 2021 Mar;39 (3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23. PMID: 33355914 Free PMC article.
  8. Charles Kouanfack 1,2,3, Liliane Mfeukeu 2,4, Sylvain Zemsi2, Martine Etoa2,4, Armel Zemsi2, Yvan Mbakop1,2, Martial Lantche3, Eric Youm5, Jean Claude Mbanya2,4, Pierre Joseph Fouda2,4, Pierre Ongolo Zogo2,4,6, Eugène Sobngwi2,3. Clinical, Biochemical and CT-Scan Characteristics of Obesity Onset in Patients under Dolutegravir in Comparison with Low-Dose-Efavirenz: A Pilot Study in Cameroon. Health Sci. Dis: Vol 22 (3) March 2021 pp 1-8
  9. Charles Kouanfack, MD, PhD1,2; Skinner Nguefack Lekelem, MD, MPH2; Fala Bede, MD, MPH3; Claude Ngwayu Nkfusai, MSc3 ;Yvette Micha Nouafo4 ; Christian Tchokonte, MD, MPH5 ; Nicaise Tsomo Zephirin, MSc2; Pierre Joseph Fouda, MD2. OPT-OUT APPROACH IN HIV TESTING Use of Trained Non-Medical Staff to Improve Access to HIV Testing Services in Africa: Implementation of the World Health Organization Opt-out Approach in Cameroon. International Journal of Maternal and Child Health and AIDS (2021), Volume 10, Issue 1, 119-127
  10. Liliane Mfeukeu-Kuate1,2, William Djomo Ngatchou3*, Mazou Ngou Temgoua2, Charles Kouanfack1,4, Daniel Lemoungoum5, Joel Noutakdie Tochie6, Armel Zemsi1, Lauriane Fomete1, Skinner Lekelem7, Sylvain Zemsi2, Joelle Sobngwi6, Thierry Ntandzi1, Christian Ngongang Ouankou4, Yves Wasnyo1, Antoinette Tsama Assiga1, Jan René Nkeck2, Ahmadou Musa Jingi8, Magellan Guewo1, Eric Walter Pefura Yone2,9, Charlotte Moussi Omgba10, Paul Owono Etoundi1,11, Jean Cyr Yombi12, Samuel Kingue2, Alain Menanga2, Jacqueline Ze Minkande11, Pierre Ongolo Zogo1,12, Jean Claude Mbanya1,2, Pierre Joseph Fouda1,11, Eugène Sobngwi1,2. Electrocardiographic Safety of Daily Hydroxychloroquine 400 mg Plus Azithromycin 250 mg as an Ambulatory Treatment for COVID-19 Patients in Cameroon. World Journal of Cardiovascular Diseases, 2021, 11, 106-112
  11. Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, Lantche Wandji M, Tetsa Tata D, Omgba Bassega P, Abong Bwenda T, Varloteaux M, Tongo M, Mpoudi-Ngolé E, Montoyo A, Mercier N, LeMoing V, Peeters M, Reynes J, Delaporte E. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Lancet HIV. 2020 Oct;7(10): e677-e687. doi: 10.1016/S2352-3018(20)30238-1. PMID: 33010241 Clinical Trial.

2020

  1. Baudoin M, Woode ME, Nishimwe ML, Lemoine M, Sylla B, Kouanfack C, Moh R, Seydi M, Rouveau N, Attia A, Lacombe K, Boyer S. Long-term clinical benefits of Sofosbuvir-based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa. Liver Int. 2020 Nov;40 (11):2643-2654. doi: 10.1111/liv.14613. Epub 2020 Aug 31. PMID: 32687669
  2. Sobngwi E, Omgba-Moussi C, Kouanfack C, Vogue N, Tchatchoua AP, Zogo PO. A review of changes in COVID-19 burden in the COVID-19 treatment centres in Yaoundé (Cameroon): a call for cautious optimism. Pan Afr Med J. 2020 Jul 14;35 (Suppl 2):113. doi: 10.11604/pamj.supp.2020.35.2.24982. E Collection 2020. PMID: 33282068 Free PMC article. No abstract available.
  3. Tagny CT, Bissim M, Djeumen R, Ngo Sack F, Angandji P, Ndoumba A, Kouanfack C, Eno L, Mbanya D, Murphy EL, Laperche S. The use of the GeeniusTM HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa. Vox Sang. 2020 Nov; 115(8):686-694. doi: 10.1111/vox.12942. Epub 2020 May 28. PMID: 32468573
  4. Kouanfack C, Unal G, Schaeffer L, Kfutwah A, Aghokeng A, Mougnutou R, Tchemgui-Noumsi N, Alessandri-Gradt E, Delaporte E, Simon F, Vray M, Plantier JC. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients.; ANRS 12168 DynaMO Study. Clin Infect Dis. 2020 Mar 17; 70 (7):1471-1477. doi: 10.1093/cid/ciz371. PMID: 31063537
  5. Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. 2-Lady Group. Pharmacoecon Open. 2020 Mar; 4 (1):45-60. doi: 10.1007/s41669-019-0157-9. PMID: 31273686 Free PMC article.
  6. Torimiro J, Yengo CK, Bimela JS, Tiedeu AB, Lebon PA, Sake CS, Kouanfack C, Nchinda G, Rowland-Jones S, Yindom LM. Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon. OMICS. 2020 Feb; 24 (2):110-115. doi: 10.1089/omi.2019.0173. Epub 2020 Jan 24. PMID: 31977279
  7. Liégeois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, Maradan G, Ducos J, Mpoudi-Ngolé E, Spire B, Delaporte E, Kuaban C, Vidal L, Laurent C; EVOLCAM study group. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM). BMC Infect Dis. 2020 Jan 15; 20 (1):49. doi: 10.1186/s12879-020-4784-7. PMID: 31941464 Free PMC article.
  8. Kouanfack C, Bede F, Nkfusai CN, Wepngong E, Venyuy MA, Hubert C, Sam DM, Cumber SN. Retention in HIV/AIDS Management Services: is it Really Poor? The Case of Yaounde Central Hospital in Cameroon. Int J MCH AIDS. 2020; 9 (2):207-212. doi: 10.21106/ijma.305. Epub 2020 May 6. PMID: 32704407 Free PMC article.
  9. Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman RS, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS. Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis. Clin Infect Dis. 2020 Jan 1; 70 (1):26-29. doi: 10.1093/cid/ciz163. PMID: 30816418 Free PMC article.

2019

  1. Nguefeu Nkenfou C, Atogho Tiedeu B, Nguefeu Nkenfou C, Nji AM, Chedjou JP, Tah Fomboh C, Kouanfack C, Mbacham WF. Adverse Drug Reactions Associated with CYP 2B6 Polymorphisms in HIV/AIDS-Treated Patients in Yaoundé, Cameroon. Appl Clin Genet. 2019 Dec 30; 12: 261-268. doi: 10.2147/TACG.S226318. E Collection 2019. PMID: 31920362 Free PMC article.
  2. Ngoufack MN, Nkenfou CN, Atogho Tiedeu B, Mouafo LCM, Dambaya B, Ndzi EN, Kouanfack C, Nguefack-Tsague G, Mbacham WF, Ndjolo A. CCR2 Genetic Polymorphism and Its Potential Effect On HIV Acquisition In A Population Of Children Living In The Northern Region Of Cameroon. Appl Clin Genet. 2019 Nov 28;12: 229-234. doi: 10.2147/TACG.S202498. E Collection 2019. PMID: 31819589 Free PMC article.
  3. Geretti AM, Abdullahi A, Mafotsing Fopoussi O, Bonnett L, Defo VF, Moudourou S, Fokam J, Kouanfack C, Torimiro J. An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy. J Antimicrob Chemother. 2019 Oct 1;74 (10):3011-3015. doi: 10.1093/jac/dkz264. PMID: 31299067 Clinical Trial.
  4. Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW, ACTA Trial Team. Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa. Clin Infect Dis. 2019 Aug 1;69(4):588-595. doi: 10.1093/cid/ciy971. PMID: 30863852 Free PMC article. Clinical Trial.
  5. Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E and NAMSAL ANRS 12313 Study Group, . Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24. PMID: 31339676 Clinical Trial.
  6. Ngouana TK, Toghueo RMK, Kenfack IF, Lachaud L, Nana AK, Tadjou L, Kouanfack C, Boyom FF, Bertout S. Epidemiology and antifungal susceptibility testing of non-albicansCandida species colonizing mucosae of HIV-infected patients in Yaoundé (Cameroon). J Mycol Med. 2019 Sep;29 (3):233-238. doi: 10.1016/j.mycmed.2019.06.003. Epub 2019 Jun 14. PMID: 31204235
  7. Abdullahi A, Fopoussi OM, Torimiro J, Atkins M, Kouanfack C, Geretti AM. Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting. Open Forum Infect Dis. 2019 Apr 3;6 (4):ofz142. doi: 10.1093/ofid/ofz142. E Collection 2019 Apr. PMID: 30968060 Free PMC article.
  8. Chabrol F, Noah Noah D, Tchoumi EP, Vidal L, Kuaban C, Carrieri MP, Boyer S; EVOLCam group. Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs. BMJ Open. 2019 Mar 20;9(3):e025415. doi: 10.1136/bmjopen-2018-025415. PMID: 30898817 Free PMC article.
  9. Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni TD, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF; ANRS 12333 Study Group. Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries. J Antimicrob Chemother. 2019 Feb 1;74 (2):462-467. doi: 10.1093/jac/dky443. PMID: 30418575 Free PMC article.
  10. Kouanfack OSD, Kouanfack C, Billong SC, Cumber SN, Nkfusai CN, Bede F, Wepngong E, Hubert C, Nguefack-Tsague G, Singwe MN. Epidemiology of Opportunistic Infections in HIV Infected Patients on Treatment in Accredited HIV Treatment Centers in Cameroon. Int J MCH AIDS. 2019;8(2):163-172. doi: 10.21106/ijma.302. Epub 2019 Dec 18. PMID: 32257607 Free PMC article.
  11. Kouanfack C, Meli H, Cumber SN, Bede F, Nkfusai CN, Ijang PY, Wepngong E, Bassong OYM, Nkoum BA. Non-Occupational HIV Post-exposure Prophylaxis: A 10-Year Retrospective Review of Data Following Sexual Exposure From Yaounde Central Hospital, Cameroon. Int J MCH AIDS. 2019;8(2):138-145. doi: 10.21106/ijma.311. Epub 2019 Dec 6. PMID: 31890345 Free PMC article.
  12. Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C; EVOLCAM study group. Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM). HIV Med. 2019 Jan; 20 (1):38-46. doi: 10.1111/hiv.12681. Epub 2018 Oct 25. PMID: 30362279
  13. Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis. 2019 Apr; 19 (4):e143-e147. doi: 10.1016/S1473-3099(18)30493-6. Epub 2018 Oct 18. PMID: 30344084 Review.
  14. Ngoufack MN, Nkenfou CN, Atogho Tiedeu B, Mouafo LCM, Dambaya B, Ndzi EN, Kouanfack C, Nguefack-Tsague G, Mbacham WF, Ndjolo A. CCR2 Genetic Polymorphism And Its Potential Effect On HIV Acquisition In A Population of Children Living In The Northern Region Of Cameroon. Appl Clin Genet. 2019 Nov 28; 12:229-234. doi: 10.2147/TACG.S202498. E Collection 2019.
  15. Abdullahi A, Fopoussi OM, Torimiro J, Atkins M, Kouanfack C, Geretti AM. Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting. Open Forum Infect Dis. 2019 Apr 3;6 (4):ofz142. doi: 10.1093/ofid/ofz142. E Collection 2019 Apr.

2018

  1. Charles Kouanfack, Mathurin Kowo, Emmanuel Sako Haddison, Veronica Matehbi Aletum, Desire Takou, Patrick Awoumou, Serge Christian Tchokonte, Samuel Sosso, Njoya Oudou and Judith Ndongo Torimiro. Undiagnosed Chronic Hepatitis B Infection and HIV Type 1 Drug Resistance Profile in AIDS Patients Receiving Tenofovir-containing Antiretroviral Regimens: Considerations for Monitoring Resistant HIV Variants during Treatment. MRJI.40801 ISSN: 2456-7043; 23(5): 1-8, 2018; (IF 4,65)
  2. Abdullahi A, Fopoussi OM, Torimiro J, Atkins M, Kouanfack C, Geretti AM. Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting. Open Forum Infect Dis. 2018 Oct 5;5(10):ofy251. doi: 10.1093/ofid/ofy251. E Collection 2018 Oct. PMID: 30377627 Free PMC article.
  3. Tchouwa GF, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, Bertagnolio S, Mpoudi-Ngole E, Raizes E, Aghokeng AF; Members of the EHRICA Study Group. Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey. J Antimicrob Chemother. 2018 Sep 1;73 (9):2468-2474. doi: 10.1093/jac/dky221. PMID: 29931063
  4. Laborde-Balen G, Taverne B, Ndour CT, Kouanfack C, Peeters M, Ndoye I, Delaporte E. The fourth HIV epidemic. Lancet Infect Dis. 2018 Apr;18 (4):379-380. doi: 10.1016/S1473-3099(18)30167-1. Epub 2018 Mar 21. PMID: 29582762 No abstract available.
  5. Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. N Engl J Med. 2018 Mar 15; 378 (11):1004-1017. doi: 10.1056/NEJMoa1710922. PMID: 29539274 Clinical Trial.
  6. Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O. Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test. Front Microbiol. 2018 Mar 13; 9:409. doi: 10.3389/fmicb.2018.00409. E Collection 2018. PMID: 29593675 Free PMC article.
  7. Tong C, Suzan-Monti M, Sagaon-Teyssier L, Mimi M, Laurent C, Maradan G, Mengue MT, Spire B, Kuaban C, Vidal L, Boyer S; EVOL Cam group. Treatment interruption in HIV-positive patients followed up in Cameroon’s antiretroviral treatment programme: individual and health care supply-related factors (ANRS-12288 EVOLCam survey). Trop Med Int Health. 2018 Mar; 23 (3):315-326. doi: 10.1111/tmi.13030. Epub 2018 Feb 2. PMID: 29327419

2017

  1. Nansseu JR, Mbogning DM, Monamele GC, Tamoh SF, Gonsu HK, Kouanfack C, Yanwou YN, Sando Z. Sero-epidemiology of human immunodeficiency virus, hepatitis B virus and hepatitis C virus: a cross-sectional survey in a rural setting of the West region of Cameroon. Pan Afr Med J. 2017 Nov 6; 28: 201. doi: 10.11604/pamj.2017.28.201.12717. E Collection 2017. PMID: 29610639 Free PMC article.
  2. Ngouana TK, Drakulovski P, Krasteva D, Toghueo RK, Kouanfack C, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S. Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients. Med Mycol. 2017 Jul 1; 55 (5):546-554. doi: 10.1093/mmy/myw108. PMID: 27744307
  3. Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A. Cryptococcal meningitis: A neglected NTD? PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. E Collection 2017 Jun. PMID: 28662028 Free PMC article. No abstract available.
  4. Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28. PMID: 28566227 Clinical Trial.
  5. Fonsah JY, Njamnshi AK, Kouanfack C, Qiu F, Njamnshi DM, Tagny CT, Nchindap E, Kenmogne L, Mbanya D, Heaton R, Kanmogne GD. Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects. PLoS One. 2017 Jan 31;12 (1):e0170893. doi: 10.1371/journal.pone.0170893. E Collection 2017. PMID: 28141867 Free PMC article.

2016

  1. Boullé C, Guichet E, Kouanfack C, Aghokeng A, Onambany B, Ikaka CM, Ngock E, Tsoumsta L, Msellati P, Mpoudi-Ngolé E, Peeters M, Delaporte E, Laurent C. Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets. Open Forum Infect Dis. 2016 Dec 20;3 (4):ofw233. doi: 10.1093/ofid/ofw233. E Collection 2016 Oct. PMID: 28018931 Free PMC article.
  2. Teto G, Fonsah JY, Tagny CT, Mbanya D, Nchindap E, Kenmogne L, Fokam J, Njamnshi DM, Kouanfack C, Njamnshi AK, Kanmogne GD. Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications. Viruses. 2016 Jul 18;8 (7):196. doi: 10.3390/v8070196. PMID: 27438849 Free PMC article.
  3. Kammalac Ngouana T, Drakulovski P, Krasteva D, Kouanfack C, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S. Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient. J Med Microbiol. 2016 Jul; 65 (7):579-589. doi: 10.1099/jmm.0.000265. Epub 2016 Apr 20. PMID: 27100672
  4. Fokam J, Takou D, Santoro MM, Akonie HZ, Kouanfack C, Ceccherini-Silberstein F, Colizzi V, Perno CF, Ndjolo A. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines. AIDS Res Hum Retroviruses. 2016 Apr; 32 (4):329-33. doi: 10.1089/AID.2015.0065. Epub 2016 Jan 20. PMID: 26602836

2015

  1. Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa. AIDS. 2015 Jul 31;29 (12):1473-81. doi: 10.1097/QAD.0000000000000709. PMID: 26244387 Free PMC article. Clinical Trial.
  2. Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C; Stratall ANRS 12110ESTHER Study Group. Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon. J Acquir Immune Defic Syndr. 2015 Jul 1;69 (3):355-64. doi: 10.1097/QAI.0000000000000604. PMID: 26181708
  3. Suzan-Monti M, Blanche J, Boyer S, Kouanfack C, Delaporte E, Bonono RC, Carrieri PM, Protopopescu C, Laurent C, Spire B. Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy]. Stratall ANRS 12110/ESTHER Study Group. HIV Med. 2015 May;16 (5):307-18. doi: 10.1111/hiv.12213. Epub 2015 Feb 27. PMID: 25721267

2014

  1. Bigna JJ, Noubiap JJ, Plottel CS, Kouanfack C, Koulla-Shiro S. Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial. Infect Dis Poverty. 2014 Dec 3;3 (1):44. doi: 10.1186/2049-9957-3-44. E Collection 2014. PMID: 25671122 Free PMC article.
  2. Kammalac Ngouana T, Dongtsa J, Kouanfack C, Tonfack C, Fomena S, Mallié M, Delaporte E, Boyom FF, Bertout S. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole. J Mycol Med. 2015 Mar;25 (1):11-6. doi: 10.1016/j.mycmed.2014.10.016. Epub 2014 Nov 21. PMID: 25467817
  3. Bigna JJ, Noubiap JJ, Plottel CS, Kouanfack C, Koulla-Shiro S. Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study. BMC Health Serv Res. 2014 Oct 26;14: 523. doi: 10.1186/s12913-014-0523-3. PMID: 25344732 Free PMC article.
  4. Ngouana TK, Krasteva D, Drakulovski P, Toghueo RK, Kouanfack C, Ambe A, Reynes J, Delaporte E, Boyom FF, Mallié M, Bertout S. Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients. Mycoses. 2015 Jan;58 (1):33-9. doi: 10.1111/myc.12266. Epub 2014 Oct 7. PMID: 25289589
  5. Mbuagbaw L, Bonono-Momnougui RC, Thabane L, Kouanfack C, Smieja M, Ongolo-Zogo P. A framework for community ownership of a text messaging programme to improve adherence to antiretroviral therapy and client-provider communication: a mixed methods study. BMC Health Serv Res. 2014 Sep 26;14: 441. doi: 10.1186/1472-6963-14-441. PMID: 25258249 Free PMC article.
  6. Bigna JJ, Noubiap JJ, Kouanfack C, Plottel CS, Koulla-Shiro S. Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial. Lancet Infect Dis. 2014 Jul;14 (7):600-8. doi: 10.1016/S1473-3099(14)70741-8. Epub 2014 Jun 2. PMID: 24932893 Clinical Trial.
  7. Meresse M, March L, Kouanfack C, Bonono RC, Boyer S, Laborde-Balen G, Aghokeng A, Suzan-Monti M, Delaporte E, Spire B, Carrieri MP, Laurent C; Stratall ANRS 12110/ESTHER Study Group. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon. HIV Med. 2014 Sep;15 (8):478-87. doi: 10.1111/hiv.12140. Epub 2014 Mar 3. PMID: 24589279
  8. Abia WA, Warth B, Sulyok M, Krska R, Tchana A, Njobeh PB, Turner PC, Kouanfack C, Eyongetah M, Dutton M, Moundipa PF. Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach. Food Chem Toxicol. 2013 Dec; 62:927-34. doi: 10.1016/j.fct.2013.10.003. Epub 2013 Oct 12. PMID: 24128729
  9. Ngatchou W, Lemogoum D, Ndobo P, Yiagnigni E, Tiogou E, Nga E, Kouanfack C, Nde F, Degaute JP, van de Borne P, Leeman M. Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients. Blood Press Monit. 2013 Oct;18 (5):247-51. doi: 10.1097/MBP.0b013e328363ee43. PMID: 23873153
  10. Bigna JJ, Kouanfack C, Noubiap JJ, Plottel CS, Koulla-Shiro S. A randomized blinded controlled trial of mobile phone reminders on the follow-up medical care of HIV-exposed and HIV-infected children in Cameroon: study protocol (MORE CARE). Trials. 2013 Sep 25;14: 313. doi: 10.1186/1745-6215-14-313. PMID: 24066735 Free PMC article. Clinical Trial.
  11. Boyer S, Laurent C, Kouanfack C, Delaporte E, Moatti JP. Laboratory monitoring for antiretroviral therapy in low-resource settings. Lancet Infect Dis. 2013 Sep;13(9):739. doi: 10.1016/S1473-3099(13)70203-2. PMID: 23969214 No abstract available.

2013

  1. Boullé C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Boyer S, Carrieri MP, Kazé S, Mben JM, Dontsop M, Spire B, Peeters M, Mpoudi-Ngolé E, Delaporte E, Laurent C; Stratall ANRS 12110/ESTHER Study Group. Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon. Clin Infect Dis. 2013 Aug;57(4):604-7. doi: 10.1093/cid/cit323. Epub 2013 May 10. PMID: 23667264
  2. Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP; Stratall ANRS 12110/ESTHER Study Group. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Lancet Infect Dis. 2013 Jul;13 (7):577-86. doi: 10.1016/S1473-3099(13)70073-2. Epub 2013 Apr 18. PMID: 23602084 Clinical Trial.
  3. Boullé C, Kouanfack C, Laborde-Balen G, Carrieri MP, Dontsop M, Boyer S, Aghokeng AF, Spire B, Koulla-Shiro S, Delaporte E, Laurent C; Stratall ANRSESTHER Study Group. Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial. J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):569-76. doi: 10.1097/QAI.0b013e318285f7b6. PMID: 23337365
  4. Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon. J Int AIDS Soc. 2013 Jan 31;16 (1):18004. doi: 10.7448/IAS.16.1.18004. PMID: 23374858 Free PMC article.
  5. Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP. Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon. Vasc Health Risk Manag. 2013;9: 509-16. doi: 10.2147/VHRM.S42350. Epub 2013 Sep 4. PMID: 24043942 Free PMC article.
  6. Ndziessi G, Cohen J, Kouanfack C, Marcellin F, Carrieri MP, Laborde-Balen G, Protopopescu C, Aghokeng AF, Moatti JP, Spire B, Delaporte E, Laurent C, Boyer S; Stratall ANRS 12110/ESTHER Study Group. Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial). PLoS One. 2013 Apr 30;8 (4):e62611. doi: 10.1371/journal.pone.0062611. Print 2013. PMID: 23638126 Free PMC article. Clinical Trial.
  7. Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP; ANRS 12110/ESTHER Study Group. Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon — data from the STRATALL ANRS 12110/ESTHER trial. AIDS Care. 2013;25 (3):347-55. PMID: 23544212
  8. Suzan-Monti M, Kouanfack C, Boyer S, Blanche J, Bonono RC, Delaporte E, Carrieri PM, Moatti JP, Laurent C, Spire B; Stratall ANRS 12-110/ESTHER Study Group. Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals. PLoS One. 2013;8 (1):e55225. doi: 10.1371/journal.pone.0055225. Epub 2013 Jan 31. PMID: 23383117 Free PMC article. Clinical Trial.
  9. Meresse M, Carrieri MP, Laurent C, Kouanfack C, Protopopescu C, Blanche J, Cohen J, Laborde-Balen G, Aghokeng AF, Spire B, Moatti JP, Delaporte E, Boyer S; Stratall ANRS 12110/ESTHER Study Group. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon. Antivir Ther. 2013;18 (1):29-37. doi: 10.3851/IMP2535. Epub 2013 Jan 29. PMID: 23358393 Clinical Trial.
  10. Ekali LG, Johnstone LK, Echouffo-Tcheugui JB, Kouanfack C, Dehayem MY, Fezeu L, Nouthe B, Hayes L, Unwin NC, Sobngwi E. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. Diabetes Metab. 2013 Feb;39(1):71-7. doi: 10.1016/j.diabet.2012.08.012. Epub 2012 Nov 13. PMID: 23153435
  11. Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Rémy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, Mallié M. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Clin Microbiol Infect. 2013 Aug;19(8):763-9. doi: 10.1111/1469-0691.12019. Epub 2012 Oct 3. PMID: 23033854

2012

  1. Aghokeng AF, Kouanfack C, Peeters M, Mpoudi-Ngole E, Delaporte E. AIDS Res Hum Retroviruses. 2013 Jan;29 (1):1-3. doi: 10.1089/aid.2012.0196. Epub 2012 Sep 11. PMID: 22889147 No abstract available.
  2. Mben JM, Kouanfack C, Essomba CN, Mbougua JB, Kenfack A, Tonfack CA, Laborde-Balen G, Bourgeois A, Biwolé-Sida M, Delaporte E, Laurent C. Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon. J Public Health Policy. 2012 Nov;33 (4):462-77. doi: 10.1057/jphp.2012.31. Epub 2012 Aug 30. PMID: 22932024
  3. Ongolo-Zogo P, Nkodo Mbia N, Mvogo Minkala TL, Biwole Sida M, Kouanfack C, Nko Amvene S. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)]. Bull Soc Pathol Exot. 2012 Dec;105 (5):353-60. doi: 10.1007/s13149-012-0253-x. Epub 2012 Aug 10. PMID: 22886433 French.
  4. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6. PMID: 23236345 Free PMC article. Clinical Trial.
  5. Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, Delaporte E, Spire B, Laurent C, Carrieri MP; Stratall ANRS 12110/ESTHER Study Group. Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial. PLoS One. 2012;7(6):e36118. doi: 10.1371/journal.pone.0036118. Epub 2012 Jun 6. PMID: 22701555 Free PMC article. Clinical Trial.

2011

  1. Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, Montavon C, Mpoudi-Ngole E, Delaporte E, Peeters M. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. AIDS. 2011 Nov 13;25(17):2183-8. doi: 10.1097/QAD. 0b013e32834bbbe9. PMID: 21860346
  2. Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, Ducos J, Delaporte E, Laurent C. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antivir Ther. 2012;17(2):321-6. doi: 10.3851/IMP1911. Epub 2011 Sep 23. PMID: 22290198
  3. Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kazé S, Molinari N, Bourgeois A, Mpoudi-Ngolé E, Spire B, Koulla-Shiro S, Delaporte E; Stratall ANRS 12110/ESTHER study group. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis. 2011 Nov;11 (11):825-33. doi: 10.1016/S1473-3099(11)70168-2. Epub 2011 Aug 8. PMID: 21831714 Clinical Trial.
  4. Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B; Stratall ANRS 12110/ESTHER Study Group. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S40-3. doi: 10.1097/QAI.0b013e318222b5c2. PMID: 21857285
  5. Rasson S, Boyer S, Fugon L, Protopopescu C, Marcellin F, Koulla-Shiro S, Kouanfack C, Spire B, Moatti JP, Carrieri MP; EVAL Study Group. Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians’ knowledge in HIV care. Antivir Ther. 2011;16(3):423-8. doi: 10.3851/IMP1773. PMID: 21555826

2010

  1. Kouanfack C, Laborde-Balen G, Aghokeng AF, Bourgeois A, Dontsop M, Mben JM, Kazé S, Mpoudi-Ngolé E, Koulla-Shiro S, Delaporte E, Laurent C; Stratall ANRS 12110/ESTHER Study Group. WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations. Trop Med Int Health. 2010 May;15 (5):580-3. doi: 10.1111/j.1365-3156.2010.02495. x. Epub 2010 Mar 1. PMID: 20214755 Clinical Trial.
  2. Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. BMC Public Health. 2010 Mar 1;10: 105. doi: 10.1186/1471-2458-10-105. PMID: 20193053 Free PMC article.
  3. Cournil A, Coudray M, Kouanfack C, Essomba CN, Tonfack CA, Biwolé-Sida M, Delaporte E, Bork K, Laurent C. Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon. Antivir Ther. 2010;15(7):1039-43. doi: 10.3851/IMP1664. PMID: 21041920
  4. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. HIV Med. 2010 Jan;11(1):85-9. doi: 10.1111/j.1468-1293.2009.00742.x. Epub 2009 Jul 29. PMID: 19659944

2009

  1. Njamnshi AK, Bissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, Fonsah JY, Kuate CT, Angwafor SA, Dema F, Njamnshi DM, Kouanfack C, Djientcheu Vde P, Muna WF, Kanmogne GD. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci. 2009 Oct 15; 285 (1-2):149-53. doi: 10.1016/j.jns.2009.06.043. Epub 2009 Jul 24. PMID: 19631349 Free PMC article.
  2. Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, Koulla-Shiro S, Mpoudi-Ngole E, Peeters M, Delaporte E. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clin Infect Dis. 2009 May 1;48 (9):1318-22. doi: 10.1086/597779. PMID: 19320592

2008

  1. Tsague L, Koulla SS, Kenfak A, Kouanfack C, Tejiokem M, Abong T, Mbangue M, Mapoure YN, Essomba C, Mosoko J, Pouillot R, Menyeng L, Epee H, Tchuani C, Zoung-Kanyi AC, Bella LA, Zekeng L. Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005. Pan Afr Med J. 2008 Jul 4;1: 2. PMID: 21532891 Free PMC article.
  2. Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YM, Essomba C, Calmy A, Mpoudi-Ngolé E, Delaporte E, Koulla-Shiro S; French National Agency for Research on AIDS 1274 Study Group. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):216-9. doi: 10.1097/QAI.0b013e3181743955. PMID: 18520681
  3. Makinson A, Moing VL, Kouanfack C, Laurent C, Delaporte E. Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings. Expert Opin Drug Saf. 2008 May;7(3):283-93. doi: 10.1517/14740338.7.3.283. PMID: 18462186 Review.
  4. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. AIDS Res Hum Retroviruses. 2008 Mar; 24 (3):393-9. doi: 10.1089/aid.2007.0219. PMID: 18327976 Clinical Trial.

2007

  1. Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine. AIDS. 2007 Mar 30;21(6):768-71. doi: 10.1097/QAD.0b013e328045c4d7. PMID: 17413701 Clinical Trial.

2006

  1. Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Antiretroviral drug resistance and routine therapy, Cameroon. Emerg Infect Dis. 2006 Jun;12(6):1001-4. doi: 10.3201/eid1206.050860. PMID: 16707062 Free PMC article.
  2. Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antivir Ther. 2006;11(5):575-9. PMID: 16964825

2004

  1. Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet. 2004 Jul 3-9;364(9428):29-34. doi: 10.1016/S0140-6736(04)16586-0. PMID: 15234853 Clinical Trial.

 2003

  1. Ayouba A, Tene G, Cunin P, Foupouapouognigni Y, Menu E, Kfutwah A, Thonnon J, Scarlatti G, Monny-Lobé M, Eteki N, Kouanfack C, Tardy M, Leke R, Nkam M, Nlend AE, Barré-Sinoussi F, Martin PM, Nerrienet E; Yaoundé European Network for the Study of In Utero Transmission of HIV-1. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):274-80. doi: 10.1097/00126334-200311010-00003. PMID: 14600571 Clinical Trial.

BOOK CHAPTER

  • KATLAMA, C. KOUANFACK, A.I. MAIGA. Gestion de l’échec thérapeutique. VIH Hépatites virale santé sexuelle. AFRAVIH 2020. Page 375. EDP Sciences.
  • Comité de rédaction – Dr Charles KOUANFACK. Mémento thérapeutique du VIH/sida en Afrique 2017. 3ieme Edition Doin Juliet 2016.
  • Dr Charles KOUANFACK, Dr Boubacar MADOUGOU. Traitement ARV de l’infection à VIH chez l’adulte et l’adolescent. Prise en charge globale des patients VIH dans les pays à ressources limitées : guide de formation à l’usage des professionnels de santé. 2ieme Edition révisée. Page 118. Expertise France Décembre 2015.

Dr Charles KOUANFACK, Dr Boubacar MADOUGOU. Traitement ARV de l’infection à VIH chez l’adulte et l’adolescent. Prise en charge globale des patients VIH dans les pays à ressources limitées : guide de formation à l’usage des paramédicaux de santé. Page 113. Edition Doin Novemb

©2017 Université de Dschang https://www.univ-dschang.org